Exosomes-Transferred lncRNA H19 Reverses Osimertinib Resistance by Upregulating PTEN via Sponging miR-148-3p in Non-Small Cell Lung Cancer
Oncology Research · 2026
DOI: 10.32604/or.2026.078665 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Weixiang Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine,…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, PTEN Phosphohydrolase, Aniline Compounds, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Oncology, Shuguang Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Institute for Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Zitieren
APA
Song, W., Zhang, Y., Shen, X., Yu, Q., Liu, Y., Yu, Y., & Chen, R. (2026). Exosomes-Transferred lncRNA H19 Reverses Osimertinib Resistance by Upregulating PTEN via Sponging miR-148-3p in Non-Small Cell Lung Cancer. Oncology Research. https://doi.org/10.32604/or.2026.078665
Vancouver
Song W, Zhang Y, Shen X, Yu Q, Liu Y, Yu Y, et al. Exosomes-Transferred lncRNA H19 Reverses Osimertinib Resistance by Upregulating PTEN via Sponging miR-148-3p in Non-Small Cell Lung Cancer. Oncology Research. 2026. doi:10.32604/or.2026.078665
BibTeX
@article{Song2026,
author = {Song, Weixiang and Zhang, Yanbo and Shen, Xubo and Yu, Qin and Liu, Yujin and Yu, Yongchun and Chen, Rui},
title = {Exosomes-Transferred lncRNA H19 Reverses Osimertinib Resistance by Upregulating PTEN via Sponging miR-148-3p in Non-Small Cell Lung Cancer},
journal = {Oncology Research},
year = {2026},
doi = {10.32604/or.2026.078665}
}
EUVIMED